Repligen | RGEN - Net Income


Repligen reported $14.91M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Agilent USD 434M 98M Sep/2025
Align Technology USD 135.76M 79.01M Dec/2025
Bio Techne USD 38.01M 176K Dec/2025
BioMarin Pharmaceutical USD -30.74M 271.28M Sep/2025
Bristol-Myers Squibb USD 2.2B 891M Sep/2025
Bruker USD -62.4M 70M Sep/2025
Charles River Laboratories USD 54.42M 2.1M Sep/2025
Danaher USD 1.2B 289M Dec/2025
Dentsply International USD -427M 382M Sep/2025
Exact Sciences USD -19.59M 18.41M Sep/2025
General Electric Aerospace USD 2.54B 384M Dec/2025
Henry Schein USD 101M 15M Sep/2025
Illumina USD 150M 85M Sep/2025
IQVIA Holdings USD 331M 65M Sep/2025
Mettler Toledo International USD 217.49M 15.14M Sep/2025
Myriad Genetics USD -27.4M 303.1M Sep/2025
Pfizer USD -1.65B 5.19B Dec/2025
Repligen USD 14.91M 44K Sep/2025
Revvity USD 46.65M 7.3M Sep/2025
Standard Biotools USD -34.69M 1.23M Sep/2025
Thermo Fisher Scientific USD 1.96B 348M Dec/2025
Waters USD 148.92M 1.81M Sep/2025
West Pharmaceutical Services USD 140M 8.2M Sep/2025